HANGZHOU, China, July 09, 2026 (GLOBE NEWSWIRE) -- MindRank AI Ltd. (“MindRank”), a clinical-stage biotechnology company dedicated to building an…
Outliyr's free public database catalogs more than seventy red light therapy panels and other light therapy devices, and publishes its…
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming…
CLEVELAND, OHIO, July 08, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public…
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of…
July 07, 2026 19:00 ET | Source: TaiMed Biologics TAIPEI, July 07, 2026 (GLOBE NEWSWIRE) -- TaiMed Biologics (TPEX: 4147)…
SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on…
Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle tissue and reduce fat infiltration in patients with…
Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective response rate vs. everolimus Garching / Munich, July…
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis July 07,…